We are live on ! Find out more
BIOA

BioAmber Inc.
BIOA

Delisted

BIOA was delisted on the 8th of February, 2018.

27 hedge funds and large institutions have $76M invested in BioAmber Inc. in 2014 Q3 according to their latest regulatory filings, with 8 funds opening new positions, 14 increasing their positions, 2 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

600% more repeat investments, than reductions

Existing positions increased: 14 | Existing positions reduced: 2

60% more first-time investments, than exits

New positions opened: 8 | Existing positions closed: 5

52% more capital invested

Capital invested by funds: $50.2M → $76M (+$25.8M)

13% more funds holding

Funds holding: 2427 (+3)

Holders
27
Holders Change
+3
Holders Change %
+12.5%
% of All Funds
0.78%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
8
Increased
14
Reduced
2
Closed
5
Calls
$1.04M
Puts
Net Calls
+$1.04M
Net Calls Change
-$45K
Name Holding Trade Value Shares
Change
Change in
Stake
WRF
1
Waddell & Reed Financial
Kansas
$45M +$17.1M +1,465,357 +48%
ACPU
2
Arrowgrass Capital Partners (US)
Delaware
$9.46M +$3.14M +268,570 +40%
PWAM
3
Park West Asset Management
California
$8.15M +$4.02M +343,247 +73%
LCS
4
Levin Capital Strategies
New York
$3.1M +$434K +37,100 +14%
PRCM
5
Pine River Capital Management
Minnesota
$2.93M +$3.44M +293,773 New
RA
6
Royce & Associates
New York
$1.66M +$16.4K +1,400 +0.8%
Deutsche Bank
7
Deutsche Bank
Germany
$1.02M +$158K +13,533 +15%
BIT
8
BlackRock Institutional Trust
California
$1.02M +$203K +17,350 +20%
CS
9
Credit Suisse
Switzerland
$549K +$517K +44,166 +408%
Geode Capital Management
10
Geode Capital Management
Massachusetts
$537K +$324K +27,714 +106%
EIM
11
Essex Investment Management
Massachusetts
$368K +$431K +36,858 New
NIMI
12
Natixis Investment Managers International
France
$319K
BCM
13
Bridgeway Capital Management
Texas
$314K
Vanguard Group
14
Vanguard Group
Pennsylvania
$307K +$359K +30,716 New
Wells Fargo
15
Wells Fargo
California
$220K +$56.6K +4,839 +28%
Goldman Sachs
16
Goldman Sachs
New York
$209K -$129K -11,026 -35%
Two Sigma Investments
17
Two Sigma Investments
New York
$197K +$230K +19,700 New
Zurich Cantonal Bank
18
Zurich Cantonal Bank
Switzerland
$150K +$176K +15,000 New
Bank of New York Mellon
19
Bank of New York Mellon
New York
$145K +$170K +14,518 New
Northern Trust
20
Northern Trust
Illinois
$127K +$148K +12,677 New
Morgan Stanley
21
Morgan Stanley
New York
$100K +$16.4K +1,400 +16%
Royal Bank of Canada
22
Royal Bank of Canada
Ontario, Canada
$85K +$32.4K +2,768 +48%
Toronto Dominion Bank
23
Toronto Dominion Bank
Ontario, Canada
$26K +$30K +2,562 New
Bank of America
24
Bank of America
North Carolina
$15K +$17.3K +1,475 +5,900%
Barclays
25
Barclays
United Kingdom
$7K +$3.65K +312 +68%

BIOA Hedge Fund Activity: Q3 2014 in Review

27 of the 3,448 institutional investors tracked by Wall St. Rank reported a position in BioAmber Inc. (BIOA) for Q3 2014, worth a combined $76M — up 52% from $50.2M a quarter earlier.

Buyers outnumbered sellers: 8 funds opened new BIOA positions and 5 closed out — a net gain of 3 holders — while 14 added to existing stakes and 2 trimmed.

The largest buyer was Waddell & Reed Financial, adding an estimated $17.1M. The largest seller was Renaissance Technologies, exiting entirely with an estimated $398K sold.

  • 27 institutional investors held BioAmber Inc. (BIOA) as of Q3 2014, up from 24 in Q2 2014.
  • Funds reported $76M of BioAmber Inc. stock for Q3 2014, up 52% quarter-over-quarter.
  • 8 funds opened new BioAmber Inc. positions in Q3 2014 and 5 closed out, a net change of +3 holders.
  • The largest BioAmber Inc. buyer in Q3 2014 was Waddell & Reed Financial, an estimated $17.1M added.
  • The largest BioAmber Inc. seller in Q3 2014 was Renaissance Technologies, an estimated $398K sold.

Based on aggregated 13F filings for Q3 2014.